{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:07:56Z","timestamp":1791562076220,"version":"4.3.4"},"reference-count":158,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1SA1G26N"],"award-info":[{"award-number":["1SA1G26N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejso.2026.111910","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:40:49Z","timestamp":1780501249000},"page":"111910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative review"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6714-8366","authenticated-orcid":false,"given":"Pieter","family":"Maerten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1200-387X","authenticated-orcid":false,"given":"Albert","family":"Wolthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"D'Hoore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Bislenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-7725","authenticated-orcid":false,"given":"Gert","family":"De Hertogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Sagaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-4582","authenticated-orcid":false,"given":"Rapha\u00ebla","family":"Dresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7331-3660","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Broeckhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertjan","family":"Rasschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Tejpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Van Herpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6372-1230","authenticated-orcid":false,"given":"Eric","family":"Van Cutsem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Dekervel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0364-682X","authenticated-orcid":false,"given":"Karin","family":"Haustermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111910_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib3","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.5445","article-title":"Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-Term results of the CAO\/ARO\/AIO-12 randomized clinical trial","volume":"8","author":"Fokas","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-Term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111910_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2022.101774","article-title":"Watch and wait: why, to whom and how","volume":"43","author":"Cerd\u00e1n-Santacruz","year":"2022","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12082873","article-title":"Watch and wait approach for rectal cancer","volume":"12","author":"Cerdan-Santacruz","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejso.2026.111910_bib9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/SLA.0000000000002761","article-title":"Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer a systematic review and pooled analysis","volume":"268","author":"Dattani","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111910_bib10","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.111910_bib11","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis","volume":"2","author":"Dossa","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2026.111910_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.116199","article-title":"Long-term recurrence patterns in rectal cancer after neoadjuvant therapy: 25-Years of real-world data","volume":"234","author":"Maerten","year":"2026","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2026.111910_bib14","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1245\/s10434-013-2910-0","article-title":"Mutations in specific codons of the KRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma","volume":"20","author":"Duldulao","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib15","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1245\/s10434-016-5205-4","article-title":"KRAS and combined KRAS\/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy","volume":"23","author":"Chow","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib16","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41591-022-01930-z","article-title":"Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer","volume":"28","author":"Chatila","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2026.111910_bib17","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1158\/1078-0432.CCR-19-0908","article-title":"Integrative molecular characterization of resistance to neoadjuvant chemoradiation in rectal cancer","volume":"25","author":"Kamran","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111910_bib18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SLA.0b013e31822b8cfa","article-title":"Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer","volume":"254","author":"Garcia-Aguilar","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111910_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.801880","article-title":"Prognostic impact of an integrative landscape of clinical, immune, and molecular features in non-metastatic rectal cancer","volume":"11","author":"Iseas","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.34880","article-title":"Clinical and genetic factors associated with tumor response to neoadjuvant (Chemo)radiotherapy, survival and recurrence risk in rectal cancer","volume":"155","author":"Hammarstr\u00f6m","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2026.111910_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00428-019-02576-y","article-title":"Mutation in BRAF and SMAD4 associated with resistance to neoadjuvant chemoradiation therapy in locally advanced rectal cancer","volume":"475","author":"Jiang","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejso.2026.111910_bib22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2026.111910_bib23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41588-022-01100-4","article-title":"Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer","volume":"54","author":"Joanito","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejso.2026.111910_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.52140","article-title":"Transcriptomic analyses of pretreatment tumor biopsy samples, response to neoadjuvant chemoradiotherapy, and survival in patients with advanced rectal cancer","volume":"6","author":"Akiyoshi","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2026.111910_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114455","article-title":"Integrative analysis of transcriptomic data reveals a predictive gene signature for chemoradiotherapy response in rectal cancer","volume":"29","author":"Corr\u00f2","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.ejso.2026.111910_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105228","article-title":"Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGF\u03b2 as key predictors","volume":"106","author":"Domingo","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejso.2026.111910_bib27","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/2767-9764.CRC-23-0502","article-title":"Stratification to neoadjuvant radiotherapy in rectal cancer by regimen and transcriptional signatures","volume":"4","author":"Mahmood","year":"2024","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.ejso.2026.111910_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106974","article-title":"Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"197","author":"Zhang","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ejso.2026.111910_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccell.2022.01.004","article-title":"Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer","volume":"40","author":"Nicolas","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejso.2026.111910_bib30","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41416-022-01842-2","article-title":"Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy","volume":"127","author":"Emons","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2026.111910_bib31","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2589-7500(19)30062-7","article-title":"Handcrafted versus deep learning radiomics for prediction of cancer therapy response","volume":"1","author":"Hosny","year":"2019","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.ejso.2026.111910_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02919-x","article-title":"Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer","volume":"19","author":"Zhuang","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejso.2026.111910_bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2019.07.033","article-title":"Predicting the tumor response to chemoradiotherapy for rectal cancer: model development and external validation using MRI radiomics","volume":"142","author":"Bulens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-022-02048-9","article-title":"Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort","volume":"17","author":"Boldrini","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib35","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2589-7500(21)00215-6","article-title":"Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study","volume":"4","author":"Feng","year":"2022","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.ejso.2026.111910_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.radonc.2021.06.019","article-title":"Image-based deep learning model for predicting pathological response in rectal cancer using post-chemoradiotherapy magnetic resonance imaging","volume":"161","author":"Jang","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22188-y","article-title":"Predicting treatment response from longitudinal images using multi-task deep learning","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejso.2026.111910_bib38","doi-asserted-by":"crossref","first-page":"E1195","DOI":"10.1097\/DCR.0000000000002931","article-title":"A longitudinal MRI-based artificial intelligence system to predict pathological complete response after neoadjuvant therapy in rectal cancer: a multicenter validation study","volume":"66","author":"Ke","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2026.111910_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mri.2019.05.003","article-title":"Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI","volume":"61","author":"Shi","year":"2019","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.ejso.2026.111910_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12071601","article-title":"Are we there yet? The value of deep learning in a multicenter setting for response prediction of locally advanced rectal cancer to neoadjuvant chemoradiotherapy","volume":"12","author":"Wichtmann","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejso.2026.111910_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1148\/radiol.2020190936","article-title":"Predicting rectal cancer response to neoadjuvant chemoradiotherapy using deep learning of diffusion kurtosis MRI","volume":"296","author":"Zhang","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2026.111910_bib42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jmri.28033","article-title":"The conversion of MRI data with multiple b-Values into signature-like pictures to predict treatment response for rectal cancer","volume":"56","author":"Zhu","year":"2022","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.ejso.2026.111910_bib43","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1002\/cam4.2636","article-title":"Predicting pathological complete response by comparing MRI-Based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer","volume":"8","author":"Li","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejso.2026.111910_bib44","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1158\/1078-0432.CCR-17-1038","article-title":"Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"23","author":"Liu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111910_bib45","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1007\/s00261-021-03219-0","article-title":"Multiparametric MRI-based Radiomics approaches on predicting response to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer","volume":"46","author":"Cheng","year":"2021","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/JCMA.0000000000000887","article-title":"Radiomic features derived from pretherapeutic MRI predict chemoradiation response in locally advanced rectal cancer","volume":"86","author":"Chou","year":"2023","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.ejso.2026.111910_bib47","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00330-018-5683-9","article-title":"Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"29","author":"Cui","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11547-020-01266-z","article-title":"A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer","volume":"126","author":"Cusumano","year":"2021","journal-title":"Radiologia Medica"},{"key":"10.1016\/j.ejso.2026.111910_bib49","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ijrobp.2018.04.065","article-title":"Magnetic resonance, vendor-independent, intensity histogram analysis predicting pathologic complete response after radiochemotherapy of rectal cancer","volume":"102","author":"Dinapoli","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2026.111910_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejrad.2019.06.013","article-title":"MR-based artificial intelligence model to assess response to therapy in locally advanced rectal cancer","volume":"118","author":"Ferrari","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib51","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00261-019-02321-8","article-title":"Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer","volume":"45","author":"van Griethuysen","year":"2020","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib52","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00261-023-04128-0","article-title":"Prediction of locally advanced rectal cancer response to neoadjuvant chemoradiation therapy using volumetric multiparametric MRI-based radiomics","volume":"49","author":"El Homsi","year":"2023","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib53","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1148\/radiol.2018172300","article-title":"Mr imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy","volume":"287","author":"Horvat","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2026.111910_bib54","article-title":"Automatic treatment outcome prediction with DeepInteg based on multimodal radiological images in rectal cancer","volume":"9","author":"Hu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ejso.2026.111910_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-023-02368-4","article-title":"Multiphase and multiparameter MRI-based radiomics for prediction of tumor response to neoadjuvant therapy in locally advanced rectal cancer","volume":"18","author":"Huang","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib56","article-title":"Pathologic complete response prediction after neoadjuvant chemoradiation therapy for rectal cancer using radiomics and deep embedding network of mri","volume":"11","author":"Lee","year":"2021","journal-title":"Appl Sci"},{"key":"10.1016\/j.ejso.2026.111910_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s12880-021-00560-0","article-title":"Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models","volume":"21","author":"Li","year":"2021","journal-title":"BMC Med Imag"},{"key":"10.1016\/j.ejso.2026.111910_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111402","article-title":"Multi-task reconstruction network for synthetic diffusion kurtosis imaging: predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer","volume":"174","author":"Ma","year":"2024","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib59","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1158\/1078-0432.CCR-15-2997","article-title":"Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI","volume":"22","author":"Nie","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111910_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231186467","article-title":"Predicting rectal cancer response to total neoadjuvant treatment using an artificial intelligence model based on magnetic resonance imaging and clinical data","volume":"22","author":"Ouyang","year":"2023","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ejso.2026.111910_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.711747","article-title":"A pipeline for predicting the treatment response of neoadjuvant chemoradiotherapy for locally advanced rectal cancer using single MRI modality: combining deep segmentation network and radiomics analysis based on \u201cSuspicious Region\u201d","volume":"11","author":"Pang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1234619","article-title":"A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"13","author":"Peng","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-10855-w","article-title":"Develop and validate a radiomics space-time model to predict the pathological complete response in patients undergoing neoadjuvant treatment of rectal cancer: an artificial intelligence model study based on machine learning","volume":"23","author":"Peng","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.111910_bib64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11605-022-05477-9","article-title":"Predicting neoadjuvant treatment response in rectal cancer using machine learning: evaluation of MRI-Based radiomic and clinical models","volume":"27","author":"Peterson","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ejso.2026.111910_bib65","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1007\/s00261-020-02502-w","article-title":"Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy","volume":"45","author":"Petkovska","year":"2020","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib66","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1007\/s00330-020-06968-6","article-title":"Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study","volume":"30","author":"Shaish","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib67","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41416-022-01786-7","article-title":"MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer","volume":"127","author":"Song","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2026.111910_bib68","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00330-022-09204-5","article-title":"External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study","volume":"33","author":"Wei","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib69","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/j.acra.2022.12.037","article-title":"MRI-based radiomic models outperform radiologists in predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"30","author":"Wen","year":"2023","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11604-022-01325-7","article-title":"Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI","volume":"41","author":"Yardimci","year":"2023","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00552","article-title":"MRI-Based radiomics predicts tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"9","author":"Yi","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib72","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1245\/s10434-020-08659-4","article-title":"Multiparametric MRI and whole slide image-based pretreatment prediction of pathological response to neoadjuvant chemoradiotherapy in rectal cancer: a multicenter radiopathomic study","volume":"27","author":"Shao","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib73","article-title":"Deep learning and radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer","volume":"8","author":"Bibault","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2026.111910_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14041079","article-title":"External validation of a radiomics model for the prediction of complete response to neoadjuvant chemoradiotherapy in rectal cancer","volume":"14","author":"Bordron","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.111910_bib75","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1007\/s00330-021-08303-z","article-title":"Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysis","volume":"32","author":"Tochigi","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.850774","article-title":"Pre-treatment computed tomography radiomics for predicting the response to neoadjuvant chemoradiation in locally advanced rectal cancer: a retrospective study","volume":"12","author":"Mao","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2022.1059033","article-title":"Interpretable machine learning for predicting pathologic complete response in patients treated with chemoradiation therapy for rectal adenocarcinoma","volume":"5","author":"Wang","year":"2022","journal-title":"Front Artif Intell"},{"key":"10.1016\/j.ejso.2026.111910_bib78","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2020.01.107","article-title":"Predicting pathological complete response in rectal cancer after chemoradiotherapy with a random forest using 18F-fluorodeoxyglucose positron emission tomography and computed tomography radiomics","volume":"8","author":"Shen","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ejso.2026.111910_bib79","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/MNM.0000000000001570","article-title":"18F-FDG-PET\/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy","volume":"43","author":"Capelli","year":"2022","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejso.2026.111910_bib80","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1007\/s00261-022-03625-y","article-title":"Endorectal ultrasound radiomics in locally advanced rectal cancer patients: despeckling and radiotherapy response prediction using machine learning","volume":"47","author":"Abbaspour","year":"2022","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib81","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jmri.27140","article-title":"Radiomic features of primary rectal cancers on baseline T2-Weighted MRI are associated with pathologic complete response to neoadjuvant chemoradiation: a multisite study","volume":"52","author":"Antunes","year":"2020","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.ejso.2026.111910_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110146","article-title":"Rectal cancer response to neoadjuvant chemoradiotherapy evaluated with MRI: development and validation of a classification algorithm","volume":"147","author":"Rengo","year":"2022","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib83","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1007\/s00261-022-03572-8","article-title":"Combined artificial intelligence and radiologist model for predicting rectal cancer treatment response from magnetic resonance imaging: an external validation study","volume":"47","author":"Horvat","year":"2022","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib84","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1148\/radiol.211986","article-title":"MRI radiomics model predicts pathologic complete response of rectal cancer following chemoradiotherapy","volume":"303","author":"Shin","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2026.111910_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123082","article-title":"Delta radiomic analysis of mesorectum to predict treatment response and prognosis in locally advanced rectal cancer","volume":"15","author":"Chiloiro","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.111910_bib86","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ijrobp.2020.07.2323","article-title":"External validation of early regression index (ERITCP) as predictor of pathologic complete response in rectal cancer using magnetic resonance-guided radiation therapy","volume":"108","author":"Cusumano","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2026.111910_bib87","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.radonc.2018.06.019","article-title":"A TCP-Based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer","volume":"128","author":"Fiorino","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14123004","article-title":"Ability of Delta radiomics to predict a complete pathological response in patients with loco-regional rectal cancer addressed to neoadjuvant chemo-radiation and surgery","volume":"14","author":"Nardone","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.111910_bib89","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.acra.2020.10.026","article-title":"MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"28","author":"Wan","year":"2021","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib90","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00330-021-08144-w","article-title":"MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer","volume":"32","author":"Jayaprakasam","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib91","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s11547-024-01796-w","article-title":"Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis","volume":"129","author":"Shen","year":"2024","journal-title":"Radiologia Medica"},{"key":"10.1016\/j.ejso.2026.111910_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1026216","article-title":"Artificial intelligence with magnetic resonance imaging for prediction of pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer: a systematic review and meta-analysis","volume":"12","author":"Jia","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib93","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1007\/s00261-025-04953-5","article-title":"MRI radiomics prediction modelling for pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis","volume":"50","author":"Rai","year":"2025","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1550838","article-title":"MRI-based radiomics for predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis","volume":"15","author":"Liao","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib95","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-023-02353-x","article-title":"THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis","volume":"18","author":"Chiloiro","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib99","article-title":"Endoscopy-Based deep convolutional neural network predicts response to neoadjuvant treatment for locally advanced rectal cancer","volume":"13","author":"Chen","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.ejso.2026.111910_bib96","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2023.14062","article-title":"Treatment response prediction of neoadjuvant chemotherapy for rectal cancer by deep learning of colonoscopy images","volume":"26","author":"Kato","year":"2023","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejso.2026.111910_bib100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/DCR.0000000000002295","article-title":"Deep learning-based model for identifying tumors in endoscopic images from patients with locally advanced rectal cancer treated with total neoadjuvant therapy","volume":"66","author":"Thompson","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2026.111910_bib98","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/j.asjsur.2023.03.165","article-title":"Deep learning of endoscopic features for the assessment of neoadjuvant therapy response in locally advanced rectal cancer","volume":"46","author":"Wang","year":"2023","journal-title":"Asian J Surg"},{"key":"10.1016\/j.ejso.2026.111910_bib97","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-024-05876-2","article-title":"Deep learning model based on endoscopic images predicting treatment response in locally advanced rectal cancer undergo neoadjuvant chemoradiotherapy: a multicenter study","volume":"150","author":"Zhang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib101","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1245\/s10434-024-15311-y","article-title":"Assessing endoscopic response in locally advanced rectal cancer treated with total neoadjuvant therapy: development and validation of a highly accurate convolutional neural network","volume":"31","author":"Williams","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib102","article-title":"Radiogenomics: contemporary applications in the management of rectal cancer","volume":"15","author":"O'Sullivan","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.111910_bib103","article-title":"MRI radiomics signature as a potential biomarker for predicting KRAS status in locally advanced rectal cancer patients","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib104","article-title":"Comparable performance of deep learning\u2013based to manual-based tumor segmentation in KRAS\/NRAS\/BRAF mutation prediction with MR-Based radiomics in rectal cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib105","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00330-022-09160-0","article-title":"Development and external validation of a multiparametric MRI-based radiomics model for preoperative prediction of microsatellite instability status in rectal cancer: a retrospective multicenter study","volume":"33","author":"Li","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.111910_bib106","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6623574","article-title":"Predicting mismatch-repair status in rectal cancer using multiparametric MRI-based radiomics models: a preliminary study","volume":"2022","author":"Jing","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejso.2026.111910_bib107","article-title":"Development and validation of magnetic resonance imaging- based radiomics models for preoperative prediction of microsatellite instability in rectal cancer","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ejso.2026.111910_bib108","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.radonc.2021.07.004","article-title":"A radiomic signature model to predict the chemoradiation-induced alteration in tumor-infiltrating CD8+ cells in locally advanced rectal cancer","volume":"162","author":"Jeon","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13050973","article-title":"Radiogenomics in colorectal cancer","volume":"13","author":"Badic","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.111910_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.722","article-title":"Radiogenomics: bridging the gap between imaging and genomics for precision oncology","volume":"5","author":"He","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.ejso.2026.111910_bib111","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/modpathol.2013.124","article-title":"Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy","volume":"27","author":"Rogers","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2026.111910_bib112","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-6-49","article-title":"Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer","volume":"6","author":"Yasuda","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib113","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/cas.13542","article-title":"Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer","volume":"109","author":"Matsutani","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2026.111910_bib114","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-014-3584-y","article-title":"CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer","volume":"21","author":"Shinto","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib115","first-page":"e1","article-title":"Tumor-infiltrating PD-1+ immune cell density is associated with response to neoadjuvant chemoradiotherapy in rectal cancer","volume":"21","author":"Kitagawa","year":"2022","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ejso.2026.111910_bib116","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-20-0337","article-title":"A diagnostic biopsy-adapted immunoscore predicts response to neoadjuvant treatment and selects patients with rectal cancer eligible for a watch-and-wait strategy","volume":"26","author":"El Sissy","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111910_bib117","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.23.00586","article-title":"International validation of the immunoscore biopsy in patients with rectal cancer managed by a watch-and-wait strategy","volume":"42","author":"El Sissy","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib118","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.humpath.2023.12.010","article-title":"Digitally assessed lymphocyte infiltration in rectal cancer biopsies is associated with pathological response to neoadjuvant therapy","volume":"144","author":"Jepsen","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2026.111910_bib123","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1016\/S2589-7500(21)00180-1","article-title":"Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from routine histology images: a retrospective study","volume":"3","author":"Bilal","year":"2021","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.ejso.2026.111910_bib129","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41591-022-02134-1","article-title":"Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer","volume":"29","author":"Foersch","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2026.111910_bib119","first-page":"223","article-title":"Predicting microsatellite instability and key biomarkers in colorectal cancer from H&E-Stained images: achieving state-of-the-art predictive performance with fewer data using Swin Transformer","volume":"9","author":"Guo","year":"2023","journal-title":"J Pathol: Clin Res"},{"key":"10.1016\/j.ejso.2026.111910_bib122","article-title":"Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology","volume":"8","author":"Gustav","year":"2024","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib127","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/his.14438","article-title":"Stromal composition predicts recurrence of early rectal cancer after local excision","volume":"79","author":"Jones","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2026.111910_bib125","article-title":"Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy","volume":"8","author":"Lafarge","year":"2024","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.compmedimag.2024.102384","article-title":"Deep neural network for the prediction of KRAS, NRAS, and BRAF genotypes in left-sided colorectal cancer based on histopathologic images","volume":"115","author":"Li","year":"2024","journal-title":"Comput Med Imag Graph"},{"key":"10.1016\/j.ejso.2026.111910_bib128","volume":"105","author":"Pai","year":"2025"},{"key":"10.1016\/j.ejso.2026.111910_bib124","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2019-319866","article-title":"Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning","volume":"70","author":"Sirinukunwattana","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.ejso.2026.111910_bib120","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.ccell.2023.08.002","article-title":"Transformer-based biomarker prediction from colorectal cancer histology: a large-scale multicentric study","volume":"41","author":"Wagner","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejso.2026.111910_bib133","article-title":"Predicting rectal cancer prognosis from histopathological images and clinical information using multi-modal deep learning","volume":"14","author":"Xu","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib132","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-13292-5","article-title":"Whole slide image based prognosis prediction in rectal cancer using unsupervised artificial intelligence","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.111910_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.110","article-title":"Predicting treatment response to neoadjuvant chemoradiotherapy in local advanced rectal cancer by biopsy digital pathology image features","volume":"10","author":"Zhang","year":"2020","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.ejso.2026.111910_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.807264","article-title":"Deep learning model for predicting the pathological complete response to neoadjuvant chemoradiotherapy of locally advanced rectal cancer","volume":"12","author":"Lou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib131","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/jmri.28108","article-title":"Selecting candidates for organ-preserving strategies after neoadjuvant chemoradiotherapy for rectal cancer: development and validation of a model integrating MRI radiomics and pathomics","volume":"56","author":"Wan","year":"2022","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.ejso.2026.111910_bib135","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1245\/s10434-011-1638-y","article-title":"Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy","volume":"18","author":"Agostini","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib142","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1158\/1078-0432.CCR-25-1242","article-title":"ctDNA longitudinal analysis during total neoadjuvant therapy and nonoperative management for locally advanced rectal cancer: a biomarker study from the NOMINATE trial","volume":"31","author":"Akiyoshi","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111910_bib139","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1078-0432.CCR-19-1996","article-title":"MRI tumor regression grade and circulating tumor DNA as complementary tools to assess response and guide therapy adaptation in rectal cancer","volume":"26","author":"Khakoo","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111910_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217442","article-title":"Longitudinal circulating tumor DNA monitoring in predicting response to short-course radiotherapy followed by neoadjuvant chemotherapy and camrelizumab in locally advanced rectal cancer: data from a Phase \u2162 clinical trial (UNION)","volume":"611","author":"Lin","year":"2025","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejso.2026.111910_bib147","article-title":"Ultrasensitive ctDNA monitoring for organ preservation in patients with locally advanced rectal cancer","volume":"10","author":"Manca","year":"2026","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/PO.20.00220","article-title":"Circulating Tumor DNA predicts pathologic and clinical outcomes following neoadjuvant chemoradiation and surgery for patients with locally advanced rectal cancer","volume":"5","author":"Mcduff","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib138","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41416-020-0941-4","article-title":"Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence","volume":"123","author":"Murahashi","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2026.111910_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01028","article-title":"Monitoring of early changes of circulating tumor DNA in the plasma of rectal cancer patients receiving neoadjuvant concomitant chemoradiotherapy: evaluation for prognosis and prediction of therapeutic response","volume":"10","author":"Pazdirek","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib136","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/annonc\/mdx778","article-title":"Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer","volume":"29","author":"Schou","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib137","first-page":"9","article-title":"Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy","volume":"36","author":"Truelsen","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ejso.2026.111910_bib141","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1158\/1078-0432.CCR-20-4769","article-title":"Clinical impact of presurgery circulating tumor DNA after total neoadjuvant treatment in locally advanced rectal cancer: a biomarker study from the GEMCAD 1402 trial","volume":"27","author":"Vidal","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111910_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003741","article-title":"Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: a prospective cohort study","volume":"18","author":"Wang","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejso.2026.111910_bib143","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1078-0432.CCR-20-2299","article-title":"Serial circulating tumor DNA in predicting and monitoring the effect of neoadjuvant chemoradiotherapy in patients with rectal cancer: a prospective multicenter study","volume":"27","author":"Zhou","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111910_bib134","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1155\/2008\/598071","article-title":"Circulating cell-free DNA in plasma of locally advanced rectal cancer patients undergoing preoperative chemoradiation: a potential diagnostic tool for therapy monitoring","volume":"25","author":"Zitt","year":"2008","journal-title":"Dis Markers"},{"key":"10.1016\/j.ejso.2026.111910_bib148","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","article-title":"A rectal cancer organoid platform to study individual responses to chemoradiation","volume":"25","author":"Ganesh","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2026.111910_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153760","article-title":"A patient-derived organoid-based radiosensitivity model for the prediction of radiation responses in patients with rectal cancer","volume":"13","author":"Park","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.111910_bib150","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/ijc.32876","article-title":"Modeling rectal cancer to advance neoadjuvant precision therapy","volume":"147","author":"Janakiraman","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2026.111910_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.039","article-title":"Developments in zebrafish avatars as radiotherapy sensitivity reporters \u2014 towards personalized medicine","volume":"51","author":"Costa","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejso.2026.111910_bib152","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49051-0","article-title":"Zebrafish Avatar-test forecasts clinical response to chemotherapy in patients with colorectal cancer","volume":"15","author":"Costa","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejso.2026.111910_bib153","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1053\/j.gastro.2021.02.020","article-title":"Microbial community heterogeneity within Colorectal Neoplasia and its correlation with Colorectal carcinogenesis","volume":"160","author":"Liu","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejso.2026.111910_bib154","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1158\/1078-0432.CCR-20-3445","article-title":"Gut microbiome components predict response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a prospective, longitudinal study","volume":"27","author":"Yi","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111910_bib155","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ijrobp.2020.04.015","article-title":"Gut microbiome composition is associated with a pathologic response after preoperative chemoradiation in patients with rectal cancer","volume":"107","author":"Jang","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2026.111910_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.562463","article-title":"The gut microbiome is associated with therapeutic responses and toxicities of neoadjuvant chemoradiotherapy in rectal cancer patients\u2014A pilot study","volume":"10","author":"Shi","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ejso.2026.111910_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1229888","article-title":"Interaction between intratumoral microbiota and tumor mediates the response of neoadjuvant therapy for rectal cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ejso.2026.111910_bib158","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-024-02492-9","article-title":"MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer","volume":"19","author":"Boldrini","year":"2024","journal-title":"Radiat Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326005299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326005299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:48:08Z","timestamp":1784238488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326005299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":158,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0748798326005299"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111910","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111910"}}